Investment Thesis
Charles River Laboratories is experiencing fundamental deterioration with negative net profitability (-1.5% net margin) and negative free cash flow (-$14.8M) despite maintaining positive operating income. Declining revenue (-0.9% YoY), minimal cash reserves ($191.8M), and substantial debt ($2.7B) create an unsustainable financial position that requires urgent operational improvement or significant debt reduction.
Strengths
- Positive operating income of $119.9M demonstrates core business profitability
- Reasonable gross margin of 30.1% indicates pricing power and competitive positioning
- Moderate leverage with Debt/Equity ratio of 0.91x, below concerning thresholds
Risks
- Negative free cash flow of -$14.8M combined with capex exceeding operating cash flow signals unsustainable cash position
- Minimal liquidity with Quick Ratio of 1.03x and only $191.8M cash against $2.7B debt creates financial vulnerability
- Declining revenue trend (-0.9% YoY) paired with negative net income suggests deteriorating operational performance and potential margin compression
Key Metrics to Watch
- Free cash flow trend and path to positive FCF generation
- Operating cash flow sustainability relative to capital expenditure requirements
- Revenue stabilization and return to growth trajectory
Financial Metrics
Revenue
995.8M
Net Income
-14.8M
EPS (Diluted)
$-0.30
Free Cash Flow
-14.8M
Total Assets
7.7B
Cash
191.8M
Profitability Ratios
Gross Margin
30.1%
Operating Margin
12.0%
Net Margin
-1.5%
ROE
-0.5%
ROA
-0.2%
FCF Margin
-1.5%
Balance Sheet & Liquidity
Current Ratio
1.36x
Quick Ratio
1.03x
Debt/Equity
0.91x
Debt/Assets
61.3%
Interest Coverage
3.43x
Long-term Debt
2.7B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T10:10:17.180760 |
Data as of: 2026-03-28 |
Powered by Claude AI